Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Mergers And Acquisition

Metacon makes Helbio its own
Metacon has acquired all outstanding shares in its existing portfolio company Helbio, which was spun out of University of Patras two decades ago.
UnifyID bands together with Prove
StartX-backed UnifyID has agreed to an acquisition by Prove for an undisclosed amount.
Clarity Informatics clears path to acquisition
Agilio Software has bought Newcastle spinout Clarity Informatics, a healthtech developer founded in 2000.
Bayer makes it two for two
Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.
Lodo likes the sound of acquisition
Zymergen has purchased Lodo Therapeutics, which is advancing Rockefeller research, for an undisclosed sum five years after the company raised its only funding round.
Effector exercises reverse merger
UC San Francisco spinout Effector Therapeutics is set to go public through a reverse merger with Locust Walk Acquisition Corp that includes a $60m PIPE financing.
Text IQ marks acquisition
Columbia’s Text IQ has been bought by Relativity for an undisclosed amount.
Glō names Nanosys as buyer
Lund spinout Glō has agreed to an acquisition by Nanosys, which will now look to strengthen its market share in TV sets and enter more markets such as AR.

Other News

Snap snatches WaveOptics in $500m deal
IP Group is exiting the diffractive waveguide producer in a cash-and-share purchase by Snap.
Adaptive3D joins Desktop Metal
Desktop Metal has paid an undisclosed amount to buy UT Dallas spinout Adaptive3D.
Cizzle checks out reverse merger
York spinout Cizzle Biotechnology has undertaken a reverse merger with Bould Opportunities to list on the London Stock Exchange.
Ginkgo Bioworks gears up for $17.5bn merger
MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market.
Soliton secures acquisition deal
AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.
Jasper Therapeutics jumps at reverse merger opportunity
The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
Tsinghua spreads $1.3bn buyout
Tsinghua University offers $1.3bn in a takeover bid of smartphone chipset manufacturer Spreadtrum.
test reg

Login